Clinical Trial Update: Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG) [Phase 3]

View source ↗

Summary

Phase 3 results evaluating the efficacy and safety of Zolpidem-MR given long-term as needed for insomnia, sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Zolpidem-MR (zolpidem)

Snippet

Sponsor: Sanofi | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: COMPLETED